BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Regan J, Murphy A, Chiang M, McMahon BP, Coughlan T, Walshe M. Botulinum toxin for upper oesophageal sphincter dysfunction in neurological swallowing disorders. Cochrane Database Syst Rev 2014;:CD009968. [PMID: 24801118 DOI: 10.1002/14651858.CD009968.pub2] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 1.9] [Reference Citation Analysis]
Number Citing Articles
1 Yim D, Seo M, Hwang SJ, Lee H, Park J. The Influence of Pharyngeal Strength on the Outcome of Botulinum Toxin Treatment for Difficulty in Relaxation of the Upper Esophageal Sphincter. Journal of the Korean Dysphagia Society 2022;12:45-49. [DOI: 10.34160/jkds.2022.12.1.005] [Reference Citation Analysis]
2 Xie M, Dou Z, Wan G, Zeng P, Wen H. Design and implementation of botulinum toxin on cricopharyngeal dysfunction guided by a combination of catheter balloon, ultrasound, and electromyography (BECURE) in patients with stroke: study protocol for a randomized, double-blinded, placebo-controlled trial. Trials 2021;22:238. [PMID: 33789722 DOI: 10.1186/s13063-021-05195-8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
3 Warnecke T, Dziewas R, Langmore S. Treatment of Neurogenic Dysphagia. Neurogenic Dysphagia 2021. [DOI: 10.1007/978-3-030-42140-3_7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Amatya B, Khan F, Galea M. Rehabilitation for people with multiple sclerosis: an overview of Cochrane Reviews. Cochrane Database Syst Rev 2019;1:CD012732. [PMID: 30637728 DOI: 10.1002/14651858.CD012732.pub2] [Cited by in Crossref: 45] [Cited by in F6Publishing: 59] [Article Influence: 15.0] [Reference Citation Analysis]
5 Eulitz N, Lauinger E. Palliative Therapie der Dysphagie. Palliative Viszeralchirurgie 2019. [DOI: 10.1007/978-3-662-57362-4_13] [Reference Citation Analysis]
6 Schradt F, Stösser S, Hänle M, Kassubek J, Lindner-Pfleghar B, Neugebauer H. [Botulinum toxin for neurogenic dysphagia after brainstem ischemia : Single injection as a treatment of an esophageal opening disorder]. Nervenarzt 2019;90:191-3. [PMID: 30171305 DOI: 10.1007/s00115-018-0603-4] [Reference Citation Analysis]
7 Sharzehi K, Schey R. The Role of Botulinum Toxin in the Gastrointestinal Tract. Botulinum Toxin Treatment in Clinical Medicine 2018. [DOI: 10.1007/978-3-319-56038-0_5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
8 Alfonsi E, Restivo DA, Cosentino G, De Icco R, Bertino G, Schindler A, Todisco M, Fresia M, Cortese A, Prunetti P, Ramusino MC, Moglia A, Sandrini G, Tassorelli C. Botulinum Toxin Is Effective in the Management of Neurogenic Dysphagia. Clinical-Electrophysiological Findings and Tips on Safety in Different Neurological Disorders. Front Pharmacol 2017;8:80. [PMID: 28275351 DOI: 10.3389/fphar.2017.00080] [Cited by in Crossref: 23] [Cited by in F6Publishing: 29] [Article Influence: 4.6] [Reference Citation Analysis]
9 Brisinda G, Sivestrini N, Bianco G, Maria G. Treatment of gastrointestinal sphincters spasms with botulinum toxin A. Toxins (Basel) 2015;7:1882-916. [PMID: 26035487 DOI: 10.3390/toxins7061882] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.9] [Reference Citation Analysis]